Key facts
- It has raised $1.9M across 1 recorded rounds; the latest was Seed Round ($1.9M) in Feb 2026.
- Notable investors include Entrepreneurs First.
- Locksmith Bio has filed 1 Form D with the SEC, most recently May 2026 ($1.9M sold to 2 investors).
- Status: Privately Held (backing).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Locksmith Bio
Create free account
No card required
Funding rounds
1 roundsAbout Locksmith Bio
Developer of physics-based artificial intelligence designed to map intrinsically disordered protein regions, revealing novel drug targets. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Amravati, India
- Founded
- 2024
- Website
- locksmithbio.org/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Locksmith Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Locksmith Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Locksmith Bio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.